Sucampo and Abbott Announce Launch of AMITIZA in Japan

[Business Wire] – BETHESDA, Md.–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Abbott (NYSE: ABT) today announced the availability of AMITIZA ® (lubiprostone) in Japan, a prescription medicine … more

View todays social media effects on ABT

View the latest stocks trending across Twitter. Click to view dashboard